期刊文献+

卡维地洛对异丙肾上腺素诱导的大鼠心肌重构中TGF-β/Smads信号传导通路的作用 被引量:7

The effect of carvedilol on TGF-beta-Smad pathways in myocardial fibrosis(MF) induced by isoproterenol
下载PDF
导出
摘要 目的研究TGF-β/Smads信号传导通路在异丙基肾上腺素诱导的心肌重构中的作用及卡维地洛的治疗机制。方法 30只SD大鼠,随机分为3组:20只SD大鼠背部皮下注射异丙基肾上腺素5 mg/(kg·d)10d,建立心肌重构模型。随机分为2组,模型组和卡维地洛组。予卡维地洛组连续灌胃卡维地洛10 mg/(kg·d)4周。4周后测心重指数(CWI);HE、Masson染色观察心肌组织病理变化;半定量RT-PCR法及免疫组化染色检测心肌组织中TGF-β1、Smad3、Smad7 mRNA及蛋白表达情况。结果模型组可见心肌细胞肥大、伸长,肌质变性,核大、深染,Masson染色可见心肌胶原纤维明显增多,治疗组大鼠心肌细胞病理改变较模型组明显减轻;CWI:模型组较对照组CWI升高(P<0.01),治疗组与模型组比较,CWI下降(P<0.01);模型组较对照组TGF-β1及Smad3 mRNA和蛋白的表达均增多(均为P<0.01),Smad7 mRNA和蛋白表达减少(分别为P<0.01和P<0.05);治疗组与模型组比较,TGF-β1及Smad3 mRNA和蛋白表达均降低(P<0.01和P<0.05),Smad7 mRNA和蛋白表达增加(P<0.01和P<0.05)。结论 TGF-β/Smads信号通路参与了异丙肾诱导的心肌重构,阻断该通路可能是卡维地洛抑制心肌重构的机制之一。 Objective To investigate the effect of TGF-beta-Smad signaling pathway in cardiac fibrosis induced by isoproterenol(ISO) in rats and the intervention mechanism of carvedilol. Methods Thirty male Sprague-Dawley rats were randomly divided into ISO model group (M group), carvedilol treatment group (T group)and control group (C group). Cardiac fibrosis models were induced in M group and T group by subcutaneous injection of ISO 5 mg/(kg . d)for 10 days. Rats of C group were injected normal saline 5 mL/(kg .d) for 10 days instead, after 10 days, rats of T group were fed carvedilol 10 mg/( kg. d) for 4 weeks. Rats of M and C group were fed normal saline 10 mL/( kg. d) for 4 weeks instead, after 4 weeks,all the rats were killed to measure the CWI. The patho- logical changes of myocardial tissue were observed by HE staining and the changes of collagen fiber were detected through Massion staining. The mRNA expression level of TGF-β1, Smad3 and Smad7 hyperplasia were deter-mined by RT-PCR. The protein level of TGF-β1, Smad3 and Smad7 were detected by immunohistochemistry. Re- suits There were changes in M group including cardiac muscle cell hypertrophy, prolongation, fibrosis and calcifi- cation presented between the cells, in addition, myocardial collagen fibers increased significantly in masson dyeing cells in M group than that in T group and C group. T group heart muscle cells showed a parallelism arrange. Be- tween the cells collagen fibers could be found, but the amount and area was decreased markedly. Compared with those of C group, all of the CWI, the expression levers of TGF-β1 mRNA, the Smad3 mRNA, TGF-β1 protein, and the Smad3 protein were significantly increased( all P 〈0. 01 ) , and the expression levers of Smad7 mRNA and the Smad7 protein were significantly lower in M group (P 〈 0. 01, P 〈 0. 05 ). However, the expression that in of TGF-β1 mRNA, Smad3 mRNA, TGF-β1 protein and Smad3 protein were much lower(P 〈 0. 01 ,P 〈 0. 05). The expression of Smad7 mRNA and the Smad7 protein were significantly higher in T group than that in M group (P 〈 0. 01 ,P 〈0. 05). Conclusions TGF-beta-Smad signaling pathway may play an important role in myocardial fibro- sis induced by ISO, and carvedilol can improve the pathological changes, which might be associated with the inhi- bition of TGF-beta-Smad signaling pathway.
出处 《基础医学与临床》 CSCD 北大核心 2013年第11期1475-1479,共5页 Basic and Clinical Medicine
关键词 心肌重构 TGF β-Smads 信号通路 卡维地洛 : ventricular remodeling transforming growth factor beta/smad signal transduction pathway carvedilol
  • 相关文献

参考文献12

  • 1Gao X, He X, Luo B, et al. Angiotensin I1 increases col- lagen espression Via transforming growth factor-betal and excracellular signal-regulated Kinase in cardiac fibroblasts [J]. Eur J Pharmacol, 2009, 606:115 - 120.
  • 2Massague J. Integration of Smad and MAPK pathways: a link and a linker revised [J]. Genes Dev, 2003, 17. 2993 - 2997.
  • 3Huang M, Sharma S, Zhu L X, et al. IL-7 inhibits fibro- blast TGF-beta production and signaling in pulmonary fibro- sis[J]. J Clin Invest, 2002, 109:931 -937.
  • 4Brooks WW, Conrad CH. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice:structural and func- tional correlates[J]. Comp Med, 2009,59:339-343.
  • 5Kumar A, Dhawan S, Aggarwal B. Emodin inhibits TNF- induced NF-KappaB activation, IkappaB degradation and expression of cell surface adhesion prot-eins in human vas- cular endothelial cells [ J ]. Oncogene, 1998, 17: 913 -918.
  • 6李军娜,刘巍,李为民.转化生长因子-β在心脏重构中作用的研究进展[J].国际免疫学杂志,2011,34(3):230-233. 被引量:4
  • 7孟国梁,吴锋,杨丽云,徐济良.苯那普利和坎地沙坦对自发性高血压大鼠心肌肥厚过程中血流动力学及TGF-β1的影响[J].基础医学与临床,2011,31(2):149-154. 被引量:2
  • 8Kiec-Wilk B, Stolarz-Skrzypek K, Sliwa A, et al. Periheral blood concentrations of TGF-IM, IGF-1 and bFGF and re- modelling of the left ventricle and blood vessels in hyperten- sive patients[J]. Kardiol Pol, 2010, 68:996-1002.
  • 9Bujak M, Ratkaj T, Bans Loncar M, et al. Microarray analysis of dupu-ytren' Disease cell : the profibrogenic role of the TGF-15 inducible P38 MAPK pathyway[ J]. Cell Physiol Biochem, 2012, 30 : 927 -942.
  • 10曾惠芬,王庆文.转化生长因子-B及其Smad信号传导的研究进展[J].国药物与临床,2010,10:1145-1147.

二级参考文献68

  • 1李学文,华琦.卡维地洛药理作用机制研究进展[J].实用医学杂志,2005,21(11):1233-1235. 被引量:21
  • 2李岳春,任江华,曹茂银.卡维地洛对柯萨奇病毒B_3病毒性心肌炎小鼠的疗效及其抗氧化应激作用[J].广东医学,2006,27(5):656-658. 被引量:6
  • 3Pfeffer MA, Braunwal DE. Ventricular remodeling after myocardial infarction: experi-mental observation and clinical implications [J]. Circulation, 1990, 81(4) : 1161 - 1172.
  • 4Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgiation in chronic heart failure [ J ]. Am J Cardiol, 1999, 83(8) : 1201 - 1205.
  • 5Almendral JL, Shick between transforming mass and diameter in Hypertens, 2010, 4: V, Rosendorff C, et al. Association growth factor-Ill and left ventricular hypertensive patients [ J ]. J Am Soc 135 - 141.
  • 6Yagi M, Kasanuki H, Hagiwara N, et al. Effect of ARB- based vs ACEI-based therapy on cardiovascular events in hypertensive patients with coronary artery desease and impaired renal function: A post hoc analysis of the HIJ-CREATE study[J]. J Hypertens, 2008, 26: 440.
  • 7Meng GL, Wu F, Yang LY, et al. Synergistic Attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan[ J]. J Cardiovasc Pharmacol, 2009, 54:16 -24.
  • 8Ferrario CM. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: Antihypertensive effects and benefits beyond BP control[J]. Life Sci, 2010, 86:289 - 299.
  • 9Mahmoudabady M, Mathieu M, Dewahcter L, et al. Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy[ J]. J Card Fail, 2008, 14 : 703 - 709.
  • 10Xu HY, Hou XW, Wang LF, et al. Association between transforming growth factor beta 1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects [ J ]. Mol Cell Biochem, 2010, 335: 13-17.

共引文献7

同被引文献60

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部